Merck | MRK - Current Liabilities


Merck reported EUR9.35B in Current Liabilities for its fiscal quarter ending in March of 2026.





Current Liabilities Change Date
Adidas EUR 9.22B 131M Jun/2026
Adyen EUR 6.79B 2.28B Dec/2025
Akzo Nobel EUR 4.31B 77M Jun/2026
Alcon AG USD 3B 45M Mar/2026
Amadeus IT EUR 3.56B 532.7M Jun/2026
Amarin USD 164.2M 15.45M Jun/2026
AstraZeneca USD 31.55B 1.02B Jun/2026
BASF EUR 20.91B 1.26B Jun/2026
Bayer EUR 33.46B 875M Mar/2026
Beiersdorf EUR 3.51B 261M Dec/2025
Covestro EUR 3.87B 299M Dec/2025
Danone EUR 16.6B 1.97B Jun/2026
Fresenius EUR 8.38B 1.18B Dec/2025
Fresenius Medical Care EUR 6.73B 484.42M Mar/2026
Genmab DKK 1.43B 686M Dec/2025
Givaudan CHF 2.35B 422M Dec/2025
GlaxoSmithKline GBP 21.53B 895M Jun/2026
GRIFOLS EUR 2.24B 112M Jun/2026
Henkel EUR 8.42B 122M Dec/2025
Hikma Pharmaceutical USD 1.45B 603M Dec/2025
Infineon EUR 6.62B 905M Mar/2026
Lakefront Biotherapeutics EUR 100.42M 52.44M Mar/2026
Linde USD 15.39B 193M Mar/2026
Lonza CHF 3.57B 421M Dec/2025
Merck EUR 9.35B 307M Mar/2026
Novartis USD 31.75B 374M Jun/2026
Philips EUR 7.42B 8M Jun/2026
Roche Holding CHF 28.85B 846M Jun/2026
Sanofi EUR 31.93B 1.92B Jun/2026
UCB EUR 4.4B 470M Dec/2025